{
  "actions": [
    {
      "acted_at": "2021-04-15",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-04-15",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1132-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-04-15",
  "number": "1132",
  "official_title": "A bill to establish a cap on out-of-pocket costs for insulin.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Ending Pricey Insulin Act",
  "sponsor": {
    "bioguide_id": "K000393",
    "district": null,
    "name": "Kennedy, John",
    "state": "LA",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-04-15",
  "subjects": [
    "Child health",
    "Digestive and metabolic diseases",
    "Employee benefits and pensions",
    "Health",
    "Health care costs and insurance",
    "Health care coverage and access",
    "Health technology, devices, supplies",
    "Inflation and prices",
    "Medicaid",
    "Medicare",
    "Military medicine",
    "Military personnel and dependents",
    "Poverty and welfare assistance",
    "Prescription drugs",
    "Veterans' medical care"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-04-15",
    "date": "2021-11-20T20:09:48Z",
    "text": "Ending Pricey Insulin Act or the EPI Act\n\nThis bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.\n\nSpecifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.\n\nThis $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.\n\nThe requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "EPI Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to establish a cap on out-of-pocket costs for insulin.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Ending Pricey Insulin Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "EPI Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:49:21Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s1132.xml"
}